Is it possible for stomach cancer to bleed after taking targeted drugs? Can it be cured?
The use of apatini, a targeted drug for gastric cancer, can cause bleeding. The treatment effect of targeted drugs for gastric cancer generally could not achieve the goal of radical cure. It could not be cured, but it could prolong survival and relieve symptoms. It was more suitable for patients with advanced gastric cancer. Read more exciting novels for free
What are the effects of taking targeted drugs in the late stage of liver cancer?
There may be the following symptoms when taking targeted drugs for late-stage liver cancer: - If the condition was under control and the tumor growth was suppressed, the tumor might shrink. - For patients with late-stage liver cancer who developed ascitic fluid, if their stomachs gradually subsided after taking the targeted drug, it might mean that the ascitic fluid decreased and the condition was controlled to a certain extent. - The patient's condition was stable. For example, although the tumor did not shrink after taking the targeted drug, its growth rate slowed down. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the 32 targeted drugs for treating cancer?
The following are some cancer-targeted drugs: - The targeted drugs for the first-line treatment of lung adenomas and lung cancer with egfr-mutation included osimertinib, dacotinib, gefitini, erlotinib, icotinib, afartinib, bevacidating, and ramulatumab; the second-line treatment (T790M positive) included osimertinib and amitini; the first-line treatment of ALK mutation included alectinib, crizotinib, ceritini, and bugatini; the second-line treatment of crizotinib-resistant included alectinib, bugatinib, and ceritini; and the second-generation targeted drugs included lorlatini. - There were also palinosetron capsules, metoclopramine tablets, ondansetron capsules, and aprepitant capsules. - Larotinib can be used to treat all advanced solid tumors with NtrK gene fusion, including 21 types of cancer, such as thyreoid cancer, myospasm, primary central nervous system tumor, sialoadenoma, Coloembryonic cancer, leukemia, breast cancer, bone sarcomas, histisarcomas, bile duct cancer, hepatic cancer, congenital mesogenic kidney cancer, primary unknown cancer, apexical cancer, liver cancer, bladder cancer, and cervical cancer. However, the number of targeted drugs explicitly mentioned at present did not reach 32, and the complete information of 32 cancer targeted drugs could not be provided. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Late stage liver cancer, taking targeted drugs, black stool discharge
There may be many reasons for black stool discharge in patients with late-stage liver cancer when taking targeted drugs. The following is the specific analysis and countermeasures: ##1. Reason Analysis 1. ** Drug factor ** - The targeted drug may cause bleeding in the digestive tract. The hemoglobinin the blood will turn black after digestion in the intestine, resulting in black feces. 2. ** Disease-related factors ** - Patients with late-stage liver cancer may have coagulated due to tumor invasion of the liver, which may lead to digestive tract bleeding. In addition, bleeding from the ruptured esophagus and gastric varices caused by portal vein hypertention was also a common cause. 3. ** Dietary factors ** - Although it is rare, eating too much black food recently (such as mulberries, animal blood products, etc.) may also cause the color of the stool to turn black. ##2. Treatment 1. ** See a doctor immediately ** - After black stool appears, the patient should immediately seek medical attention and describe the symptoms and medication to the doctor in detail. 2. ** Complete relevant checks ** - The doctor may arrange for a stool occult blood test, a colonoscopy, and other examinations to determine if there is any bleeding in the digestive tract and its cause. 3. ** Adjusts treatment plan ** - According to the results of the examination, the doctor may adjust the dose of the targeted drug or change the drug to reduce the risk of digestive tract bleeding. 4. ** Bleeding control treatment ** - If a diagnosis of digestive tract bleeding was confirmed, the doctor might give hemostatic drugs (such as vitamins K1, tranexamic acid, etc.) to promote the synthesis of blood clot factors and reduce bleeding. 5. ** Protect gastric mucus ** - The damaged liver function of patients with late-stage liver cancer may affect the secretion and secretion of bile, causing bile to flow back into the stomach and cause damage to the gastric mucus. At this time, you can use a protective agent for the digestive tract (such as aluminum magnesite, sucralfate, etc.) to neutralize gastric acid and protect the gastric mucus. 6. ** Nutritional support ** - Patients with late-stage liver cancer were usually in poor physical condition, and nutritional supplements (such as compound aa, fat milk, etc.) could provide the necessary nutrients to support the patient's recovery process. 7. ** Pay attention to rest ** - The patient should pay attention to rest and avoid overwork to avoid increasing the burden on the liver. In short, the blackness of patients with late-stage liver cancer during targeted drug therapy was a symptom that needed to be taken seriously. Patients should pay close attention to the changes in their symptoms. If they have persistent black stool or other discomfort symptoms, they should inform the doctor in time. At the same time, they should maintain good eating habits, avoid eating food that may increase the burden on the stomach and intestines, and follow the doctor's advice for treatment and adjustment. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
A year after taking targeted drugs for lung cancer, my sternum hurts a little
A year after a lung cancer patient took the targeted drug, there could be a variety of reasons for the pain in the sternum. On the one hand, this may be a side effect of the targeted drug. For example, gefitini may cause chest pain, which is usually mild and may gradually reduce as the drug continues to be used. On the other hand, lung cancer itself could also cause chest pain, especially when the disease progressed to the late stage. In addition, if the patient also had heart disease, such as heartache, similar symptoms might appear. Therefore, it was recommended that patients who experienced stabbing pain in their sternum should seek medical attention in time for a detailed examination. The doctor would conduct a comprehensive analysis based on the patient's specific condition, combined with factors such as drug use history and disease history to determine the specific cause of the stinging pain. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
There are several types of breast cancer targeted drugs
There were mainly the following types of breast cancer targeted drugs: 1. Anti-neoplastic targeted drugs: There are intravenous preparations and oral drugs, but the effect in the treatment of breast cancer is not ideal. For example, bevacidol (Avastin) will be considered in some cases. 2. Anti-Her- 2 targeted drugs: targeted at HER - 2 positive patients, it is the most important targeted drug for breast cancer, mainly including trastuzumab (Herceptin), pertubizab, dm- 1, lapatini, etc. The prerequisite for use was that the patient was positive for HER - 2 (+++ in the immune tissue test). If the immune tissue test was ++, the patient would need to undergo a further FISH test. The patient could only be used if the FISH test was positive. If the immune tissue test was + or-, the patient could not be used. 3. A targeted drug for patients with fetal mutations in the Brca lineage: The main drug is olaparib, which is used to treat patients with metastasizing breast cancer who have harmful or suspected harmful mutations in the Brca lineage and who are negative for the human embryonic growth factor receptor 2 (HEL2). 4. Immune therapy (in a sense, it was also a targeted drug): Anti-PD- 1/PD-L1 Monoclone Antibodies, which essentially relieved immune suppression and activated immune cells to kill cancer cells. 5. mTO inhibition drugs, such as everolimus and sirolimus, can inhibit the activation of the mTO signaling pathway, thereby suppressing the growth and metabolism of tumor cells. 6. Other targeted therapy drugs, such as Parp inhibition drugs, CD 4/6 inhibition drugs, etc. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it always effective to take targeted drugs for lung cancer?
The effect of targeted drugs on lung cancer patients was not very good. Target drugs could not cure lung cancer. Although they could prolong survival time, they could not always be effective. There were very few driver mutations in lung cancer, so there were relatively few targeted drugs that could be used. When using targeted drugs, it was necessary to find the target of lung cancer and could not be used blindly. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it useful to take targeted drugs for esophagus cancer metastasizing?
At present, a variety of targeted drugs were available for the treatment of esophagus cancer, including new small molecules multi-target Tyrosin Kinase Inhibition, drugs that targeted HEL2, cetuxed that targeted the egFr target, and bevacizumb that targeted the veg-like growth factor target, etc. There was also a combination of PD1 - 1 inhibition and targeted HEL2 for the treatment of cancer at the gastric-esophagus junction. Chinese studies have shown that as a new small-molecular multi-target Tyrosinase Kinase Inhibition, anlotinib and apitini have a certain effect in the treatment of esophagus cancer. The combination therapy of trastuzumab-targeted to HEL2 and PD1 inhibition drugs (such as pembrolizumab) combined with chemotherapy can be used as the first-line treatment for cancer of the gastroesophagus junction, advanced gastric cancer with HEL2 positive, and esophagus cancer. In the second-line treatment of China guidelines for the treatment of esophagus cancer, level II recommendations were given to anlotinib (Class 2A) and apitini (Class 3). However, there were no phase III clinical trials to prove that molecular targeted drugs could prolong the survival of patients with esophagus cancer. The effect of targeted therapy needed further study. In general, molecular targeted therapy had a certain clinical value for the treatment of patients with esophagus cancer, including those with metastasizing, but it still needed further in-depth research. These drugs must be used under the guidance of a professional doctor. It is not recommended for patients to buy and take them themselves to avoid serious adverse reactions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What targeted drugs can be taken for oral cancer?
The targeted drugs for oral squamous-cell cancer included pabolizumab injection, trastubizab for injection, erlotinib, gefitinib, cetuxed, nivaliumab, etc. Pabolizub injection can be used to treat advanced non-small cell lung cancer, advanced gastric cancer, oral Squamoma, etc.; Trastuzu for injection can be used to treat metastasized breast cancer, metastasized gastric cancer, oral Squamoma, etc.; Erlotinib is suitable for patients with advanced non-small cell lung cancer who have a mutation in Exon 19 or L858 of the Epidermal growth factor receptor Tyrosin Kinase gene. It can block the egf-signaling pathway to inhibit the growth of tumor cells; Gefitini can be used for the treatment of patients with locally advanced or metastasized non-small cell lung cancer who have failed at least one previous chemotherapy program. It can selectively inhibit the activity of EGFR protein protein. Cetuxed is suitable for the auxiliary treatment of RAS gene wild-type Colon Cancer, Rectal Cancer, and Stomach Cancer. It can be used in combination with radiation to improve the efficacy. Nivaliumab is suitable for the treatment of patients with advanced liver cancer who have failed previous systematic treatment. It activates T cells, allowing them to recognize and attack tumor cells that express the PD - 1 receptor. When using these drugs, you must follow the doctor's advice and pay attention to their respective conditions and precautions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for small cell lung cancer?
Currently, targeted drugs specifically for small cell lung cancer have not been approved for marketing, but there are other types of targeted drugs that can be used to treat small cell lung cancer. For example, anlotinib, a new small-molecular multi-target tropinase inhibition drug, has anti-tumor vasodification effects and has been used in the third-line treatment of small cell lung cancer; Nivaliumab was approved for the treatment of patients with metastasized small cell lung cancer who had previously received platinum-based chemotherapy and at least one other therapy; Drulimucomab can be used in combination with chemotherapy to treat extensive small cell lung cancer; Atelibiza can be used in combination with chemotherapy to treat first-line treatment of extensive small cell lung cancer; There were also apatinib, niraparik, pembrolizib, and so on. In addition, as an anti-viral and anti-tumor immune regulator, Interferon can be used in the treatment of lung cancer; Bendamustine is an egf-receptor antagonist, which can reduce the side effects of patients and achieve a certain effect; Imatini suppresses the growth of cancer cells, prolonging the survival of patients and reducing adverse reactions; Perindopril Fumarate is an oral neo-vasodilator, which can suppress tumor neo-vasodillations and slow down tumor growth. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the names of targeted drugs for head and neck cancer?
As for head and neck tumors, because most head and neck tumors occur in the mucus membrane, more than 90% of them are positive for the receptor for the growth factor of the human skin. Target drugs such as cetuxed mainly act on the growth factor of the human skin. Cetuxed combined with chemotherapy can achieve better efficacy in the treatment of head and neck tumors and reduce tumor relapse and migration. In addition, Bevacobin, Duostat, etc. can inhibit tumor neoplasia and thus tumor growth. However, there was no specific mention of targeted drugs for head and neck adenomas. There was only information on targeted drugs for head and neck tumors. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>